Abstract
We report a case of primary cutaneous aspergillosis in an immunocompetent child that responded rapidly to oral voriconazole therapy. Voriconazole may be considered as a treatment option for pediatric patients with primary cutaneous aspergillosis.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 493-495 |
| Number of pages | 3 |
| Journal | Pediatric Dermatology |
| Volume | 26 |
| Issue number | 4 |
| DOIs | |
| State | Published - Jul 2009 |
| Externally published | Yes |
ASJC Scopus subject areas
- Dermatology
- Pediatrics, Perinatology, and Child Health